MAM
KLRS

Marquette Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Marquette Asset Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,778
Closed -$145K – 236
2024
Q3 		$145K Hold
7,778
– – 0.02% 115
2024
Q2 		$129K Hold
7,778
– – 0.02% 92
2024
Q1 		$135K Buy
+7,778
New +$135K 0.02% 94